Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Gene expression profile of Mycobacterium tuberculosis in a non-replicating state.
Muttucumaru, DG N; Roberts, G; Hinds, J; STABLER, RA; Parish, T;
2004
Tuberculosis (Edinburgh, Scotland), (2004).84 3-4 10.1016/j.tube.2003.12.006.
Clinical features, diagnosis, and management of multiple drug-resistant tuberculosis since 2002.
Drobniewski, F; Balabanova, Y; COKER, R;
2004
Current opinion in pulmonary medicine, (2004).10 3 10.1097/00063198-200405000-00011.
Treating malaria in Africa.
GREENWOOD, B;
2004
BMJ, (2004).328 7439 10.1136/bmj.328.7439.534.
Different resistance mutations can be detected simultaneously in the blood and the lung of HIV-1 infected individuals on antiretroviral therapy.
White, NC; Israel-Biet, D; COKER, RJ; Mitchell, DM; Weber, JN; Clarke, JR;
2004
Journal of medical virology, (2004).72 3 10.1002/jmv.20010.
Targetable water-soluble polymer-drug conjugates for the treatment of visceral leishmaniasis.
Nan, A; CROFT, SL; YARDLEY, V; Ghandehari, H;
2004
Journal of controlled release, (2004).94 1 10.1016/j.jconrel.2003.09.012.
Estimating the public health cost of antimicrobial resistance in Europe: the example of MRSA [Report to the European Commission].
Van der Bruggen, T; Jansen, W; Monnet, DL; SMITH, RD; Verhoef, J; Fluit, A;
2004
(2004).
Review: multidrug-resistant tuberculosis: public health challenges.
COKER, RJ;
2004
Tropical medicine & international health, (2004).9 1 10.1046/j.1365-3156.2003.01156.x.
[Presence of the double pfmdr1 mutation 86Tyr and 1246 Tyr in clones of a chloroquine-resistant west African isolate of Plasmodium falciparum].
Pinheiro, L; Franco, S; Adagu, IS; Rosa, R; Rosário, VE; WARHURST, DC;
2003
Acta medica portuguesa, (2003).16 4
Hydroxychloroquine is much less active than chloroquine against chloroquine-resistant Plasmodium falciparum, in agreement with its physicochemical properties.
WARHURST, DC; Steele, JC P; Adagu, IS; Craig, JC; Cullander, C;
2003
The Journal of antimicrobial chemotherapy, (2003).52 2 10.1093/jac/dkg319.
A prioritised research agenda for DOTS-Plus for multidrug-resistant tuberculosis (MDR-TB).
Gupta, R; Espinal, M; Stop TB Working Group on DOTS-Plus for MDR-TB,;
2003
The international journal of tuberculosis and lung disease, (2003).7 5